Neuracle has achieved a significant milestone with its Neuracle NEO-ONE SCI device, marking the world's first invasive brain-computer interface (BCI) product to enter clinical use. The device received its first prescription at Shanghai Huashan Hospital, signifying the completion of its commercial cycle from regulatory approval to surgical implantation and subsequent insurance coverage. AI
IMPACT This marks a critical step in the clinical application of brain-computer interfaces, potentially paving the way for wider adoption in medical treatments.
RANK_REASON First commercial cycle completion of an invasive BCI device. [lever_c_demoted from significant: ic=1 ai=0.7]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
